Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATAMYCIN vs NAXITAMAB-GQGK: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATAMYCIN vs NAXITAMAB-GQGK: Safety Overview

Metric NATAMYCIN NAXITAMAB-GQGK
Total FAERS Reports 258 152
Deaths Reported 61 2
Death Rate 23.6% 1.3%
Hospitalizations 101 56
Average Patient Age 57.9 yrs 7.5 yrs
% Female Patients 50.0% 53.4%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Harrow Eye, LLC N/A
Route OPHTHALMIC N/A
Marketing Status Prescription Prescription